OSRH Stock Summary and Trading Ideas (Osr Holdings | NASDAQ:OSRH)

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.

Osr Holdings trades on the NASDAQ stock market under the symbol OSRH.

As of May 27, 2026, OSRH stock price declined to $0.48 with 1,845,203 million shares trading.

OSRH has a beta of 1.94, meaning it tends to be more sensitive to market movements. OSRH has a correlation of 0.05 to the broad based SPY ETF.

OSRH has a market cap of $16.99 million. This is considered a Sub-Micro Cap stock.

Last quarter Osr Holdings reported $484,057 in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-294,443 and exceeded earnings estimates by $.20.

The top ETF exchange traded funds that OSRH belongs to (by Net Assets): VXF.

OSRH has underperformed the market in the last year with a price return of -58.3% while the SPY ETF gained +30.9%. However, in the short term, OSRH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +15.2% vs +9.1% return in SPY. But in the last 2 weeks, OSRH shares have been beat by the market, returning -24.6% compared to an SPY return of +1.7%.

OSRH support price is $.45 and resistance is $.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSRH shares will trade within this expected range on the day.